blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2726062

EP2726062 - MULTILAYERED DOSAGE FORM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.12.2019
Database last updated on 17.07.2024
FormerExamination is in progress
Status updated on  18.08.2017
Most recent event   Tooltip05.12.2019Application deemed to be withdrawnpublished on 01.01.2020  [2020/01]
Applicant(s)For all designated states
Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1
Western Express Highway, Goregaon (E)
400 063 Mumbai
MAH / IN
[2016/17]
Former [2014/19]For all designated states
Ranbaxy Laboratories Limited
Head Office: 12th Floor Devika Tower 06 Nehru Place
New Delhi, Delhi 110019 / IN
Inventor(s)01 / BHAVARISETTI, Murali, Krishna
s/o B. V. SATYANARAYANA
D. No. 16-5 Ramalayam Street
Nandigama
Krishna Andhra Pradesh 521185 / IN
02 / VIVEK, Kumaravel
145/1 Purasawalkam High Road
Kellys
Chennai Tamil Nadu 600010 / IN
03 / NARRAVULA, Sreekanth
House 2-39-9a Sakhamurivari Street
Gandhi Nagar
Tenali
Guntur Andhra Pradesh 522201 / IN
04 / SINGH, Romi, Barat
A-14 Badshah Bagh
Varanasi Uttar Pradesh 221002 / IN
 [2014/19]
Representative(s)Cronin, Brian Harold John
c/o Gsmart IP SA
Route de Florissant 81
1206 Genève / CH
[N/P]
Former [2014/19]Cronin, Brian Harold John
CRONIN Intellectual Property Chemin de Précossy 31
1260 Nyon / CH
Application number, filing date12747937.629.06.2012
WO2012IB53341
Priority number, dateIN2011DEL184129.06.2011         Original published format: IN DE18412011
[2014/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013001516
Date:03.01.2013
Language:EN
[2013/01]
Type: A1 Application with search report 
No.:EP2726062
Date:07.05.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2013 takes the place of the publication of the European patent application.
[2014/19]
Search report(s)International search report - published on:EP03.01.2013
ClassificationIPC:A61K9/20, A61K31/137, A61K31/138, A61K31/366, A61K31/445, A61K31/455, A61K31/55
[2014/19]
CPC:
A61K9/209 (EP,US); A61K31/137 (EP,US); A61K31/138 (EP,US);
A61K31/366 (EP,US); A61K31/445 (EP,US); A61K31/455 (EP,US);
A61K31/55 (EP,US); A61K31/554 (EP,US); A61K9/2009 (US);
A61K9/2018 (US); A61K9/2027 (US); A61K9/2054 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/19]
TitleGerman:MEHRSCHICHTIGE DARREICHUNGSFORM[2014/19]
English:MULTILAYERED DOSAGE FORM[2014/19]
French:FORME GALÉNIQUE MULTICOUCHE[2014/19]
Entry into regional phase29.01.2014National basic fee paid 
29.01.2014Designation fee(s) paid 
29.01.2014Examination fee paid 
Examination procedure29.01.2014Examination requested  [2014/19]
04.09.2014Amendment by applicant (claims and/or description)
02.06.2016Despatch of a communication from the examining division (Time limit: M04)
04.10.2016Reply to a communication from the examining division
08.08.2017Despatch of a communication from the examining division (Time limit: M04)
25.10.2017Reply to a communication from the examining division
21.03.2019Despatch of a communication from the examining division (Time limit: M04)
01.08.2019Application deemed to be withdrawn, date of legal effect  [2020/01]
26.08.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/01]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.06.2016
Fees paidRenewal fee
30.06.2014Renewal fee patent year 03
30.06.2015Renewal fee patent year 04
30.06.2016Renewal fee patent year 05
30.06.2017Renewal fee patent year 06
02.07.2018Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.06.201908   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO03075897  (JAGOTEC AG [CH], et al) [X] 1-18,20,21,23,27,28 * abstract * * figures 1-3 * * page 4, lines 15-23 *;
 [X]EP0631775  (EKITA INVESTMENTS NV [NA]) [X] 1-18,20,21,23,27,28 * abstract * * figures 2,3 * * page 3, lines 1-25 *
by applicantUS5318558
 US5221278
 US7387793
 US6797283
 US6183778
 US5783212
 US5626874
 US2010040681
 US5549913
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.